{"id":5567,"date":"2014-07-01T08:23:00","date_gmt":"2014-07-01T08:23:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=5567"},"modified":"2021-07-12T07:49:29","modified_gmt":"2021-07-12T07:49:29","slug":"first-successful-use-of-leukocyte-apheresis-as-maintenance-therapy-for-crohns-disease-in-the-united-kingdom","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/fr\/professional\/scientific-corner\/first-successful-use-of-leukocyte-apheresis-as-maintenance-therapy-for-crohns-disease-in-the-united-kingdom\/","title":{"rendered":"First successful use of leukocyte apheresis as maintenance therapy for Crohn&rsquo;s disease in the United Kingdom."},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Tate+D&amp;cauthor_id=24243700\">David Tate<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24243700\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Cairnes+V&amp;cauthor_id=24243700\">Vida Cairnes<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Valori+R&amp;cauthor_id=24243700\">Roland Valori<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Makins+R&amp;cauthor_id=24243700\">Richard Makins<\/a>, J Clin Apher. 2014 Jun;29(3):181-2<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>We describe the case of a 24 year old male with severe fistulating Crohn&rsquo;s disease who failed mutliple modalities of medical and surgical therapy. We present objective and subjective evidence of disease remission after induction and maintenance treatment with leukocyte apheresis. This is the first described case of successful maintenance treatment of severe Crohn&rsquo;s disease with leukocyte apheresis in the United Kingdom.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24243700\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/24243700\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>David Tate&nbsp;1,&nbsp;Vida Cairnes,&nbsp;Roland Valori,&nbsp;Richard Makins, J Clin Apher. 2014 Jun;29(3):181-2 We describe the case of a 24 year old male with severe fistulating Crohn&rsquo;s disease who failed mutliple modalities of medical and surgical therapy. We present objective and subjective evidence of disease remission after induction and maintenance treatment with leukocyte apheresis. This is the first [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[159],"class_list":["post-5567","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-crohns-disease"],"acf":{"sc_authors":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>First successful use of leukocyte apheresis as maintenance therapy for Crohn&#039;s disease in the United Kingdom. - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-successful-use-of-leukocyte-apheresis-as-maintenance-therapy-for-crohns-disease-in-the-united-kingdom\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First successful use of leukocyte apheresis as maintenance therapy for Crohn&#039;s disease in the United Kingdom. - Adacyte\" \/>\n<meta property=\"og:description\" content=\"David Tate&nbsp;1,&nbsp;Vida Cairnes,&nbsp;Roland Valori,&nbsp;Richard Makins, J Clin Apher. 2014 Jun;29(3):181-2 We describe the case of a 24 year old male with severe fistulating Crohn&rsquo;s disease who failed mutliple modalities of medical and surgical therapy. We present objective and subjective evidence of disease remission after induction and maintenance treatment with leukocyte apheresis. This is the first [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-successful-use-of-leukocyte-apheresis-as-maintenance-therapy-for-crohns-disease-in-the-united-kingdom\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-12T07:49:29+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-successful-use-of-leukocyte-apheresis-as-maintenance-therapy-for-crohns-disease-in-the-united-kingdom\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-successful-use-of-leukocyte-apheresis-as-maintenance-therapy-for-crohns-disease-in-the-united-kingdom\/\",\"name\":\"First successful use of leukocyte apheresis as maintenance therapy for Crohn's disease in the United Kingdom. - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2014-07-01T08:23:00+00:00\",\"dateModified\":\"2021-07-12T07:49:29+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-successful-use-of-leukocyte-apheresis-as-maintenance-therapy-for-crohns-disease-in-the-united-kingdom\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First successful use of leukocyte apheresis as maintenance therapy for Crohn's disease in the United Kingdom. - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-successful-use-of-leukocyte-apheresis-as-maintenance-therapy-for-crohns-disease-in-the-united-kingdom\/","og_locale":"fr_FR","og_type":"article","og_title":"First successful use of leukocyte apheresis as maintenance therapy for Crohn's disease in the United Kingdom. - Adacyte","og_description":"David Tate&nbsp;1,&nbsp;Vida Cairnes,&nbsp;Roland Valori,&nbsp;Richard Makins, J Clin Apher. 2014 Jun;29(3):181-2 We describe the case of a 24 year old male with severe fistulating Crohn&rsquo;s disease who failed mutliple modalities of medical and surgical therapy. We present objective and subjective evidence of disease remission after induction and maintenance treatment with leukocyte apheresis. This is the first [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-successful-use-of-leukocyte-apheresis-as-maintenance-therapy-for-crohns-disease-in-the-united-kingdom\/","og_site_name":"Adacyte","article_modified_time":"2021-07-12T07:49:29+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-successful-use-of-leukocyte-apheresis-as-maintenance-therapy-for-crohns-disease-in-the-united-kingdom\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-successful-use-of-leukocyte-apheresis-as-maintenance-therapy-for-crohns-disease-in-the-united-kingdom\/","name":"First successful use of leukocyte apheresis as maintenance therapy for Crohn's disease in the United Kingdom. - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2014-07-01T08:23:00+00:00","dateModified":"2021-07-12T07:49:29+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-successful-use-of-leukocyte-apheresis-as-maintenance-therapy-for-crohns-disease-in-the-united-kingdom\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner\/5567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=5567"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific_tags?post=5567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}